Annual SG&A
$13.91 M
-$4.79 M-25.61%
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual selling, general & administrative expenses is currently $13.91 million, with the most recent change of -$4.79 million (-25.61%) on 31 December 2023. During the last 3 years, it has fallen by -$14.57 million (-51.16%). CRBP annual SG&A is now -51.16% below its all-time high of $28.48 million, reached on 31 December 2020.CRBP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.70 M
+$574.00 K+13.92%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly selling, general & administrative expenses is currently $4.70 million, with the most recent change of +$574.00 thousand (+13.92%) on 30 September 2024. Over the past year, it has increased by +$1.76 million (+59.93%). CRBP quarterly SG&A is now -39.31% below its all-time high of $7.74 million, reached on 30 June 2020.CRBP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.80 B
-$38.70 M-2.20%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings TTM selling, general & administrative expenses is currently -$1.80 billion, with the most recent change of -$38.70 million (-2.20%) on 30 September 2024. Over the past year, it has dropped by -$1.82 billion (-11842.07%). CRBP TTM SG&A is now -95373.86% below its all-time high of $29.40 million, reached on 30 September 2020.CRBP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.6% | +59.9% | -10000.0% |
| 3 y3 years | -51.2% | -11.0% | -8457.9% |
| 5 y5 years | +7.4% | -15.1% | -8634.7% |
CRBP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.2% | at low | -11.0% | +59.9% | -38.5% | at low |
| 5 y | 5 years | -51.2% | +7.4% | -39.3% | +59.9% | -210.2% | at low |
| alltime | all time | -51.2% | +3913.2% | -39.3% | >+9999.0% | <-9999.0% | at low |
Corbus Pharmaceuticals Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.70 M(+13.9%) | $15.80 M(+12.5%) |
| June 2024 | - | $4.12 M(+6.8%) | $14.04 M(+1.3%) |
| Mar 2024 | - | $3.86 M(+23.6%) | $13.86 M(-0.3%) |
| Dec 2023 | $13.91 M(-25.6%) | $3.12 M(+6.4%) | $13.91 M(-9.3%) |
| Sept 2023 | - | $2.94 M(-25.5%) | $15.34 M(-6.9%) |
| June 2023 | - | $3.94 M(+0.8%) | $16.48 M(-5.2%) |
| Mar 2023 | - | $3.91 M(-14.2%) | $17.38 M(-7.1%) |
| Dec 2022 | $18.70 M(-8.5%) | $4.55 M(+11.8%) | $18.70 M(+1.7%) |
| Sept 2022 | - | $4.07 M(-15.8%) | $18.38 M(-6.1%) |
| June 2022 | - | $4.84 M(-7.5%) | $19.58 M(-3.6%) |
| Mar 2022 | - | $5.23 M(+23.5%) | $20.32 M(-0.5%) |
| Dec 2021 | $20.43 M(-28.3%) | $4.23 M(-19.8%) | $20.43 M(-5.2%) |
| Sept 2021 | - | $5.28 M(-5.3%) | $21.55 M(-10.0%) |
| June 2021 | - | $5.57 M(+4.3%) | $23.96 M(-8.3%) |
| Mar 2021 | - | $5.34 M(-0.4%) | $26.12 M(-8.3%) |
| Dec 2020 | $28.48 M(+20.5%) | $5.36 M(-30.2%) | $28.48 M(-3.1%) |
| Sept 2020 | - | $7.68 M(-0.7%) | $29.40 M(+7.9%) |
| June 2020 | - | $7.74 M(+0.5%) | $27.25 M(+10.2%) |
| Mar 2020 | - | $7.70 M(+22.7%) | $24.72 M(+4.5%) |
| Dec 2019 | $23.64 M | $6.28 M(+13.4%) | $23.64 M(+12.0%) |
| Sept 2019 | - | $5.53 M(+6.3%) | $21.10 M(+12.6%) |
| June 2019 | - | $5.21 M(-21.4%) | $18.75 M(+13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $6.62 M(+77.3%) | $16.53 M(+27.6%) |
| Dec 2018 | $12.96 M(+44.5%) | $3.74 M(+17.5%) | $12.96 M(+9.9%) |
| Sept 2018 | - | $3.18 M(+6.5%) | $11.79 M(+9.8%) |
| June 2018 | - | $2.99 M(-2.0%) | $10.74 M(+11.5%) |
| Mar 2018 | - | $3.05 M(+18.4%) | $9.63 M(+7.5%) |
| Dec 2017 | $8.96 M(+38.8%) | $2.58 M(+20.9%) | $8.96 M(+0.1%) |
| Sept 2017 | - | $2.13 M(+13.4%) | $8.96 M(+4.3%) |
| June 2017 | - | $1.88 M(-21.1%) | $8.59 M(+11.1%) |
| Mar 2017 | - | $2.38 M(-7.3%) | $7.73 M(+19.7%) |
| Dec 2016 | $6.46 M(+78.8%) | $2.57 M(+45.8%) | $6.46 M(+30.9%) |
| Sept 2016 | - | $1.76 M(+72.4%) | $4.93 M(+24.5%) |
| June 2016 | - | $1.02 M(-8.0%) | $3.96 M(+1.3%) |
| Mar 2016 | - | $1.11 M(+6.5%) | $3.91 M(+8.2%) |
| Dec 2015 | $3.61 M(+159.7%) | $1.04 M(+31.8%) | $3.61 M(+10.9%) |
| Sept 2015 | - | $790.60 K(-18.4%) | $3.26 M(+15.0%) |
| June 2015 | - | $969.10 K(+19.4%) | $2.83 M(+31.2%) |
| Mar 2015 | - | $811.90 K(+18.1%) | $2.16 M(+55.2%) |
| Dec 2014 | $1.39 M(+301.5%) | $687.50 K(+88.0%) | $1.39 M(+39.8%) |
| Sept 2014 | - | $365.60 K(+24.0%) | $995.70 K(+54.0%) |
| June 2014 | - | $294.90 K(+574.8%) | $646.50 K(+83.9%) |
| Mar 2014 | - | $43.70 K(-85.0%) | $351.60 K(+14.2%) |
| Dec 2013 | $346.60 K | $291.50 K(+1677.4%) | $307.90 K(+1777.4%) |
| Sept 2013 | - | $16.40 K | $16.40 K |
FAQ
- What is Corbus Pharmaceuticals Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual SG&A year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly SG&A year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM SG&A year-on-year change?
What is Corbus Pharmaceuticals Holdings annual selling, general & administrative expenses?
The current annual SG&A of CRBP is $13.91 M
What is the all time high annual SG&A for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual selling, general & administrative expenses is $28.48 M
What is Corbus Pharmaceuticals Holdings annual SG&A year-on-year change?
Over the past year, CRBP annual selling, general & administrative expenses has changed by -$4.79 M (-25.61%)
What is Corbus Pharmaceuticals Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of CRBP is $4.70 M
What is the all time high quarterly SG&A for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly selling, general & administrative expenses is $7.74 M
What is Corbus Pharmaceuticals Holdings quarterly SG&A year-on-year change?
Over the past year, CRBP quarterly selling, general & administrative expenses has changed by +$1.76 M (+59.93%)
What is Corbus Pharmaceuticals Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of CRBP is -$1.80 B
What is the all time high TTM SG&A for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM selling, general & administrative expenses is $29.40 M
What is Corbus Pharmaceuticals Holdings TTM SG&A year-on-year change?
Over the past year, CRBP TTM selling, general & administrative expenses has changed by -$1.82 B (-11842.07%)